60 related articles for article (PubMed ID: 11798848)
1. [Epitope of somatic mutations in the hepatocyte growth factor receptor naturally processed and presented by HLA-A2 on human hepatocellular carcinoma].
Guo A; Sui Y; Ye J
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):30-2. PubMed ID: 11798848
[TBL] [Abstract][Full Text] [Related]
2. [Identification of a naturally presented MAGE-A3 epitope on the surface of HLE cell line by mass spectrometry].
Peng JR; Dong N; Liu HW; Leng XS
Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):595-7. PubMed ID: 17688791
[TBL] [Abstract][Full Text] [Related]
3. [Prediction synthesis and identification of HLA-A2-restricted cytotoxic T lymphocyte epitopes of the tumor antigen MAGE-n].
Dong HL; Sui YF; Ye J; Li ZS; Qu P; Zhang XM; Chen GS; Lu SY
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1080-3. PubMed ID: 12899783
[TBL] [Abstract][Full Text] [Related]
4. Identification of two naturally presented MAGE antigenic peptides from a patient with hepatocellular carcinoma by mass spectrometry.
Zhou M; Peng JR; Zhang HG; Wang HX; Zhong ZH; Pan XY; Chen WF; Leng XS
Immunol Lett; 2005 Jun; 99(1):113-21. PubMed ID: 15885805
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Alisa A; Ives A; Pathan AA; Navarrete CV; Williams R; Bertoletti A; Behboudi S
Clin Cancer Res; 2005 Sep; 11(18):6686-94. PubMed ID: 16166448
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.
Capo S; Nuti S; Scarselli M; Tavarini S; Montigiani S; Mori E; Finco O; Abrignani S; Grandi G; Bensi G
Vaccine; 2005 Oct; 23(42):5028-37. PubMed ID: 15982792
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
Komori H; Nakatsura T; Senju S; Yoshitake Y; Motomura Y; Ikuta Y; Fukuma D; Yokomine K; Harao M; Beppu T; Matsui M; Torigoe T; Sato N; Baba H; Nishimura Y
Clin Cancer Res; 2006 May; 12(9):2689-97. PubMed ID: 16675560
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
[TBL] [Abstract][Full Text] [Related]
9. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
Boesen A; Sundar K; Coico R
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1223-30. PubMed ID: 16210487
[TBL] [Abstract][Full Text] [Related]
10. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
11. Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587.
Xing Q; Pang XW; Peng JR; Yin YH; Li Y; Yu X; Zhou SP; Zhang Y; Chen WF
Biochem Biophys Res Commun; 2008 Jul; 372(2):331-5. PubMed ID: 18498761
[TBL] [Abstract][Full Text] [Related]
12. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
13. Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.
Dong HL; Sui YF; Li ZS; Qu P; Wu W; Ye J; Zhang XM; Lu SY
Cancer Lett; 2004 Aug; 211(2):219-25. PubMed ID: 15219945
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.
Park WS; Dong SM; Kim SY; Na EY; Shin MS; Pi JH; Kim BJ; Bae JH; Hong YK; Lee KS; Lee SH; Yoo NJ; Jang JJ; Pack S; Zhuang Z; Schmidt L; Zbar B; Lee JY
Cancer Res; 1999 Jan; 59(2):307-10. PubMed ID: 9927037
[TBL] [Abstract][Full Text] [Related]
15. Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma.
Yang JM; Wang HJ; Du L; Han XM; Ye ZY; Fang Y; Tao HQ; Zhao ZS; Zhou YL
Cancer Immunol Immunother; 2009 Sep; 58(9):1387-96. PubMed ID: 19169879
[TBL] [Abstract][Full Text] [Related]
16. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
[TBL] [Abstract][Full Text] [Related]
17. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
18. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)].
Guo J; Cai M; Wei D; Qin L; Huang J; Wang X
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):178-80. PubMed ID: 12113671
[TBL] [Abstract][Full Text] [Related]
19. The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.
Sørensen RB; Junker N; Kirkin A; Voigt H; Svane IM; Becker JC; thor Straten P; Andersen MH
Cancer Immunol Immunother; 2009 May; 58(5):665-75. PubMed ID: 18828018
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
Terasawa H; Tsang KY; Gulley J; Arlen P; Schlom J
Clin Cancer Res; 2002 Jan; 8(1):41-53. PubMed ID: 11801539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
